Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.

Endocrinology and metabolism clinics of North America - 1 Mar 1996

Wohllk N, Cote G J, Evans D B, Goepfert H, Ordonez N G, Gagel R F

Abstract excerpt

Application of RET proto-oncogene mutation analysis to the clinical management of MEN 2 and FMTC has simplified and enhanced the power of earlier used screening and treatment efforts for hereditary MTC. The approaches outlined herein are cost-effective, have improved diagnostic accuracy, and hold the promise of improved cure rates for this neoplasm. Further studies to elucidate the mechanism by which these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Sequence Data

Share to Mutation

Share to Pedigree

Share to Proto-Oncogene Mas

Share to Proto-Oncogenes

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 8907678
DOI: 10.1016/s0889-8529(05)70310-8

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.PMID 8907678Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.Semantic proximity Read ↗

Molecular advances in medullary thyroid cancer diagnostics.Semantic proximity Read ↗

Utility of RET mutation analysis in multiple endocrine neoplasia type 2.Semantic proximity Read ↗

RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.Semantic proximity Read ↗

Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.Semantic proximity Read ↗

Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management.Semantic proximity Read ↗

Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitorsSemantic proximity Read ↗

Utilization of Genetic Testing for RET Mutations in Patients with Medullary Thyroid Carcinoma: a Single-Center Experience.Semantic proximity Read ↗

Genetic Testing for Familial CancerSemantic proximity Read ↗

Perspective on RET proto-oncogene and thyroid cancer.Semantic proximity Read ↗

Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.